Synthetic
cannabinoid receptor agonists (SCRAs), termed “Spice”
or “K2”, are molecules that emulate the effects of the
active ingredient of marijuana, and they have gained enormous popularity
over the past decade. SCRAs are Schedule 1 drugs that are highly prevalent
in the U.K. prison system and among homeless populations. SCRAs are
highly potent and addictive. With no way to determine the dose/amount
at the point-of care, they pose severe health risks to users, including
psychosis, stroke, epileptic seizures, and they can kill. SCRAs are
chemically diverse, with over a hundred compounds used as recreational
drugs. The chemical diversity of SCRA structures presents a challenge
in developing detection modalities. Typically, GC-MS is used for chemical
identification; however, this cannot be in place in most settings
where detection is critical, e.g., in hospital Emergency Departments,
in custody suites/prisons, or among homeless communities. Ideally,
real time, point-of-care identification of SCRAs is desirable to direct
the care pathway of overdoses and provide information for informed
consent. Herein, we show that fluorescence spectral fingerprinting
can be used to identify the likely presence of SCRAs, as well as provide
more specific information on structural class and concentration (∼1
μg mL–1). We demonstrate that that fluorescence
spectral fingerprints, combined with numerical modeling, can detect
both parent and combusted material, and such fingerprinting is also
practical for detecting them in oral fluids. Our proof-of-concept
study suggests that, with development, the approach could be useful
in a range of capacities, notably in harm reduction for users of Spice/K2.